Previous studies have shown that IL-6 is a proinflammatory cytokine, and its release can induce a series of downstream proinflammatory responses, which serve as an important pathway for inducing cytokine storms in COVID-19 patients.499,500 In response, tocilizumab was designed to alleviate cytokine storms in COVID-19 patients. Here, IL6 is linked to COVID-19.